Global interventional radiology demand is forecast to reach US$ 42.7 Billion and grow at 5% CAGR.
| Attributes | Details |
|---|---|
| Interventional Radiology Market CAGR (2022 to 2032) | 5% |
| Interventional Radiology Market (2032) | US$ 42.7 Billion |
| Interventional Radiology Market Attraction | Increased Research and Development efforts, rising usage of interventional radiology, and new product development are the market attractions. |
Interventional radiology (IR) is imaging-guided or radiologically guided medical procedures that ensure safety, accuracy, and comfort for the patient. As medicine and surgery move towards less and less invasive treatments and more effective ones, IR is now a major sector of innovation that is responding to societal demands for more and better treatments.
An emerging trend in IR is the development of an ambulatory shift as it offers significant savings and quality improvements to patient care. Both guidance methods and interventional radiology equipment are major areas of development when it comes to innovation in the field of radiology. Personalized medicine and new drugs targeted to optimize tolerance to treatment and maximize effectiveness are changing all organ diseases, but oncology has made the greatest strides.
An emerging medical specialty, interventional radiology, allows radiologists to diagnose, treat, and cure various diseases using minimally invasive techniques. A specialist who specializes in interventional radiology uses imaging techniques such as MRIs, CT scans, and ultrasonography to take a look inside the body.
Compared to open surgery, interventional radiology procedures are usually less invasive. Consequently, interventional radiology markets are anticipated to grow. Major surgery is considered a risky and costly procedure whereas interventional radiology is regarded as a safe and effective alternative treatment. Further, the IR procedure comes with a lower risk of serious side effects compared to open surgery, despite the fact that open surgeries involve some major risks during and after the procedure.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Due to the growing adoption of image-based therapeutic interventions, the Asia Pacific region dominates the interventional radiology market. A growing geriatric population, improving healthcare infrastructure, and higher healthcare expenditures are the main factors driving the growth in the market. The region also offers interventional radiology training programs that contribute to the rapid growth of this market.
Players operating in the interventional radiology products market have significant growth opportunities in emerging markets like China, India, and Brazil. Since these countries have less stringent regulatory policies and low competition, they should experience high growth in the next few years.
New therapeutic concepts and innovative techniques have continually emerged in interventional radiology (IR), attracting the attention of scientists for their many potential uses. Embolization therapy, interventional oncology, and vascular interventions are among the newest techniques, involving either unexplored applications or cutting-edge innovations.
The new paradigm in interventional radiology is to use multimodality image fusion-guided procedures. In conjunction with preoperative imaging, cone-beam computed tomography (CBCT) has proven to be an invaluable tool in the performance of complex endovascular repairs, embolization, and interventional oncological procedures. New start-ups and commercial companies are gaining interest in using augmented reality and virtual reality as part of a multimodal orientation in the guidance process, as these technologies have the potential of integrating multimodality guidance effectively.
As the Mixed Reality concept (MxR) provides the ability to preserve the surroundings while allowing interactions with digital objects, it makes a more suitable application for medical procedures. Patients' data can be visualized intraprocedural, organ anatomy can be reconstructed in 3D for interactive multimedia assessments and to train doctors and preoperative information can be provided to patients and their families. Innovations in technology and medical practice are undeniably driving the evolution of interventional radiology; still, interventional radiologists need to focus on the clinical value and multidisciplinary management of their patients.
Chronic illnesses are increasing the demand for quality scanning, X-ray vision, and treatment technologies in hospitals; thus, the introduction of interventional radiology is considered helpful with steady market growth.
Interventional radiology for medical students has improved dramatically in recent years. Government and non-government groups are promoting chronic illness awareness and treatment through interventional radiology. WHO is aggressively working to enhance and sustain cancer and cardiovascular disease treatment globally.
These government agencies aim to ensure patients have access to world-class treatment and quick diagnosis. Thus, many governments are focusing on developing creative techniques to improve access to excellent care. In India, new approaches have been devised to better monitor these and other illnesses.
Also, in recent years, awareness of the need for early diagnosis and treatment has increased in underdeveloped nations. The radiology tech intervention involves minimally invasive methods such as X-ray fluoroscopy, abdominal imaging, MRI, and ultrasound.
Compared to open surgery, this reduces risks, and discomfort, and improves recovery. The high cost of ultrasound-guided interventional procedures such as X-ray systems, MRI scanners, and CT scanners operate as a key barrier for the industry, especially in emerging nations. Due to these factors, the abdominal imaging equipment market has grown at a normal pace.
Principal Consultant
The market is being driven by the growing popularity of minimally invasive treatments such as ultrasound-guided interventional procedures which offer cost-effective solutions and require less hospitalization.
Patients are treated swiftly and are typically discharged from the hospital the same day using minimally invasive procedures. The majority of these techniques include the use of abdominal imaging technology. The interventional radiology industry is being driven by advancements in imaging technologies that offer surgeons real-time views of internal organs while diagnosing.
Augmented reality and artificial intelligence are the primary areas of progress. In contrast to virtual reality, which does not allow doctors to move items (scopes and devices) within the body or interact with their surroundings, augmented reality enables doctors to move objects (scopes and devices) within the body and interact with their surroundings.
This dynamic evolution has a plethora of implications for image-based therapies. Complex algorithms are used by artificial intelligence to detect abnormalities and anomalies in medical imaging, such as CT scans and X-ray tech.
What are the Limits to the Interventional Radiology Market?
Market growth may be harmed in emerging nations with lower income levels due to the high costs associated with minimally invasive medical treatments. However, governments in a number of underdeveloped nations are taking steps to minimize the cost of therapy.
The interventional radiology market growth may be constrained by a lack of awareness in developing and underdeveloped nations. The COVID-19 epidemic had a somewhat negative effect on the interventional radiology market share because of regulatory constraints affecting hospital and healthcare services globally.
Due to the disruption of the healthcare system, the pandemic had a substantial influence on the operation of general hospital treatments for non-COVID-19 patients in hospitals worldwide. The cardiac interventional radiography domain bore a disproportionate part of the disruption caused by the pandemic in the healthcare industry.
What are the Emerging Trends in Interventional Radiology Market?
The increased incidence of chronic illnesses such as cancer and cardiovascular problems among adults and elderly patients is fueling demand for minimally invasive treatment alternatives and is one of the primary drivers of the interventional radiology market growth. Patients with chronic conditions can be treated using a variety of interventional radiology technologies, including CT scans, MRIs, and ultrasounds.
Numerous psychological elements associated with surgical operations in patients have demonstrated a good trend for market increase. Minimally invasive operations have grown in popularity due to their cost-effectiveness and shorter hospital stay.
These therapies have extended patients' life expectancy and established a sufficient level of prevalence to have a significant influence on the market. The availability of low-cost technology and cost-effective therapy has boosted patient reliance on interventional radiology.
Patients who get appropriate therapy are predicted to have fewer co-morbid illnesses and are at a decreased risk of developing them. Thus, the continually expanding patient population has increased the demand for interventional radiology therapy, which in turn has increased the rate of minimally invasive method adoption.
Angioplasty is a minimally invasive procedure used to treat vascular disorders. Numerous hospitals and healthcare centers have incorporated the interventional radiology procedure of angioplasty into their treatment protocols for patients with cardiovascular and peripheral vascular problems. X-ray fluoroscopy or other imaging techniques are used to guide a balloon-tipped catheter (a long, thin plastic tube) into the restricted or blocked artery or vein.
How are Some Challenges Stifling Interventional Radiology Market Growth?
The high cost of digital emergency radiology devices such as CT scanners, x-ray tech, and MRI scanners will act as challenges to the market expansion. Additionally, dangers associated with excessive radiation exposure and fierce rivalry among market participants will put the interventional radiology business under pressure.
However, a scarcity of trained individuals and a lack of knowledge would serve as a challenge and further slow the market's development pace. Additionally, the country part of the interventional radiology market study discusses specific market-impacting aspects and changes in domestic legislation that affect the market's present and future trends.
Consumption quantities, manufacturing locations and volumes, import-export analysis, price trend analysis, raw material costs, and downstream and upstream value chain analysis are only a few of the primary indicators utilized to anticipate the market situation for particular nations.
The existence and availability of global brands, as well as the obstacles they encounter owing to intense or sparse competition from local and domestic brands, as well as the influence of domestic tariffs and trade routes, are considered when forecasting nation statistics.
The interventional radiology market is segmented by product (MRI systems, ultrasound imaging systems, CT scanners, angiography systems, fluoroscopy systems, and biopsy devices), application (cardiology, urology, and nephrology, oncology, and gastroenterology, among others), and region (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America).
The market study estimates market volumes and trends for 17 distinct countries located in significant worldwide regions. The study includes the market value (in USD Billion) of each of the segments mentioned above.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
MRI systems, CT scanners, ultrasonic imaging systems, angiography systems, fluoroscopy systems, biopsy devices, and others are split by product type. This is because CT scanners combine X-ray pictures from various angles across the body to generate cross-sectional images or slices of blood arteries, tissues, and bones.
Technological advances in the healthcare industry are projected to fuel market expansion. Angiography, angioplasty, biopsy, embolization, thrombolysis, vertebroplasty, nephrostomy, and others are separated by procedure type.
Angiography is predicted to be the interventional radiology market dominators procedure type. The market is growing due to the rising demand for minimally invasive procedures and rising cardiovascular disease prevalence. And it gives you real-time imagery for improved therapy. This will also fuel market expansion over the predicted period.
The market is divided into cardiology, oncology, gastroenterology, urology & nephrology, obstetrics & gynecology, and others. The interventional radiology market is expected to be driven by the cardiology application type segment because of rising cardiovascular disorders and an aging population. Radiologists employ ultrasonography, CT scans, and MRIs to diagnose and treat heart problems.
The rising burden of chronic illnesses and the desire for less costly therapies are pushing the market in the USA. It is commonly used to identify and treat cardiac problems. The USA performs about a million cardiac catheterizations and angiographic operations each year. Several radiological treatments exist for cancer patients.
The United States has the second-highest number of prevalent cancer cases among all ages, having 8,432,938 new cases of cancer in the past five years. The high incidence of instances suggests the greater patient need for radiological procedures, driving demand in the region.
New product innovations and releases are likely to fuel market expansion in Canada. For example, Guerbet, a global leader in abdominal imaging, reported in May 2020 that their Vectorio kit for imaging HCC had been approved in Canada. Cancer and diabetes are on the rise, as are the chances for minimally invasive, tailored therapies employing imaging guidance.
Among the industry's leading participants are Koninklijke Philips, GE Healthcare, Siemens Healthineers, Fujifilm Healthcare, Canon Medical Systems Corporation, and Toshiba Medical Systems. These industry leaders are deploying sophisticated technology to address a sizable portion of the consumer market's unmet demands.
Recent Developments in the Interventional Radiology Market:
The interventional radiology market is anticipated to expand at a consistent CAGR of 5% throughout the forecast period.
In 2021, the interventional radiology market was estimated to be worth US$ 25 Billion.
By 2032, the worldwide interventional radiology market is estimated to be worth nearly US$ 42.7 Billion.
North America is a significant market for interventional radiology.
By 2026, the interventional radiology market is anticipated to reach roughly US$ 32 Billion.
1. Executive Summary | Interventional Radiology Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. FMI Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Demand
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in Optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2015 to 2021 and Forecast, 2022 to 2032
6.1. Historical Market Analysis, 2015 to 2021
6.2. Current and Future Market Projections, 2022 to 2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2015 to 2021 and Forecast, 2022 to 2032
7.1. Historical Market Value (US$ Million) Analysis, 2015 to 2021
7.2. Current and Future Market Value (US$ Million) Projections, 2022 to 2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Product
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Product, 2015 to 2021
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Product, 2022 to 2032
8.3.1. MRI Systems
8.3.2. CT Scanners
8.3.3. Ultrasound Imaging Systems
8.3.4. Angiography Systems
8.3.5. Others
8.4. Market Attractiveness Analysis By Product
9. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By End-use
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By End-use, 2015 to 2021
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-use, 2022 to 2032
9.3.1. Hospitals
9.3.2. Clinics
9.3.3. Ambulatory Surgical Centres
9.3.4. Others
9.4. Market Attractiveness Analysis By End-use
10. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Procedure
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By Procedure, 2015 to 2021
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Procedure, 2022 to 2032
10.3.1. Angioplasty
10.3.2. Biopsy
10.3.3. Embolization
10.3.3.1. Peripheral Embolization
10.3.3.2. Prostatic Artery Embolization
10.3.3.3. Genicular Artery Embolization
10.3.3.4. Fibroid
10.3.3.5. Others
10.3.4. Thrombolysis
10.3.5. Vertebroplasty
10.3.6. Nephrostomy
10.3.7. Interventional Oncology
10.3.8. MSK Intervention
10.3.9. Others
10.4. Market Attractiveness Analysis By Procedure
11. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Million) Analysis By Application, 2015 to 2021
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2022 to 2032
11.3.1. Cardiology
11.3.2. Oncology
11.3.3. Urology
11.3.4. Gastroenterology
11.3.5. Obstetrics
11.3.6. Gynaecology
11.3.7. Others
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2015 to 2021 and Forecast 2022 to 2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$ Million) Analysis By Region, 2015 to 2021
12.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2022 to 2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
13.4.1. By Country
13.4.1.1. USA
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Product
13.4.3. By End-use
13.4.4. By Application
13.4.5. By Procedure
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product
13.5.3. By End-use
13.5.4. By Application
13.5.5. By Procedure
14. Latin America Market Analysis 2015 to 2021 and Forecast 2022 to 2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Product
14.4.3. By End-use
14.4.4. By Application
14.4.5. By Procedure
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product
14.5.3. By End-use
14.5.4. By Application
14.5.5. By Procedure
15. Europe Market Analysis 2015 to 2021 and Forecast 2022 to 2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. United Kingdom
15.4.1.4. Italy
15.4.1.5. Benelux
15.4.1.6. Nordic Countries
15.4.1.7. Rest of Europe
15.4.2. By Product
15.4.3. By End-use
15.4.4. By Application
15.4.5. By Procedure
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product
15.5.3. By End-use
15.5.4. By Application
15.5.5. By Procedure
16. Asia Pacific Market Analysis 2015 to 2021 and Forecast 2022 to 2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
16.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. Rest of Asia Pacific
16.4.2. By Product
16.4.3. By End-use
16.4.4. By Application
16.4.5. By Procedure
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product
16.5.3. By End-use
16.5.4. By Application
16.5.5. By Procedure
17. Middle East and Africa Market Analysis 2015 to 2021 and Forecast 2022 to 2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2015 to 2021
17.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2022 to 2032
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. South Africa
17.4.1.3. Turkey
17.4.1.4. Rest of Middle East and Africa
17.4.2. By Product
17.4.3. By End-use
17.4.4. By Application
17.4.5. By Procedure
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product
17.5.3. By End-use
17.5.4. By Application
17.5.5. By Procedure
18. Key Countries Market Analysis 2015 to 2021 and Forecast 2022 to 2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. USA Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.2.2.1. By Product
18.2.2.2. By End-use
18.2.2.3. By Application
18.2.2.4. By Procedure
18.3. Canada Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.3.2.1. By Product
18.3.2.2. By End-use
18.3.2.3. By Application
18.3.2.4. By Procedure
18.4. Mexico Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.4.2.1. By Product
18.4.2.2. By End-use
18.4.2.3. By Application
18.4.2.4. By Procedure
18.5. Brazil Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.5.2.1. By Product
18.5.2.2. By End-use
18.5.2.3. By Application
18.5.2.4. By Procedure
18.6. Germany Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.6.2.1. By Product
18.6.2.2. By End-use
18.6.2.3. By Application
18.6.2.4. By Procedure
18.7. France Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.7.2.1. By Product
18.7.2.2. By End-use
18.7.2.3. By Application
18.7.2.4. By Procedure
18.8. Italy Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.8.2.1. By Product
18.8.2.2. By End-use
18.8.2.3. By Application
18.8.2.4. By Procedure
18.9. BENELUX Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.9.2.1. By Product
18.9.2.2. By End-use
18.9.2.3. By Application
18.9.2.4. By Procedure
18.10. United Kingdom Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.10.2.1. By Product
18.10.2.2. By End-use
18.10.2.3. By Application
18.10.2.4. By Procedure
18.11. Nordic Countries Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.11.2.1. By Product
18.11.2.2. By End-use
18.11.2.3. By Application
18.11.2.4. By Procedure
18.12. China Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.12.2.1. By Product
18.12.2.2. By End-use
18.12.2.3. By Application
18.12.2.4. By Procedure
18.13. Japan Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.13.2.1. By Product
18.13.2.2. By End-use
18.13.2.3. By Application
18.13.2.4. By Procedure
18.14. South Korea Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.14.2.1. By Product
18.14.2.2. By End-use
18.14.2.3. By Application
18.14.2.4. By Procedure
18.15. GCC Countries Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.15.2.1. By Product
18.15.2.2. By End-use
18.15.2.3. By Application
18.15.2.4. By Procedure
18.16. South Africa Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.16.2.1. By Product
18.16.2.2. By End-use
18.16.2.3. By Application
18.16.2.4. By Procedure
18.17. Turkey Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2015 to 2032
18.17.2.1. By Product
18.17.2.2. By End-use
18.17.2.3. By Application
18.17.2.4. By Procedure
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional Footprint of Players
19.4.2. Product Footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. Koninklijke Philips N. V
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Carestream Health Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Hologic, Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. GE Healthcare
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Fujifilm Corporation
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. Samsung Healthcare (Samsung Electronics Co., Ltd.)
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
20.3.7. Shimadzu Corporation
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Sales Footprint
20.3.7.4. Strategy Overview
20.3.8. Siemens Healthineers
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Sales Footprint
20.3.8.4. Strategy Overview
20.3.9. Canon Medical Systems Corporation
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Sales Footprint
20.3.9.4. Strategy Overview
20.3.10. Olympus Corporation
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Sales Footprint
20.3.10.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Interventional Radiology Market
